FDA.reportPublic FDA data

Equate Multi-Symptom Relief Eye Drops

Manufacturer
Walmart, Inc. | KC Pharmaceuticals, Inc.
Effective date
2025-12-30
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 01:30:47

Label at a glance#

ProductEquate Multi-Symptom Relief Eye Drops
Active ingredientZINC SULFATE, POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HYDROCHLORIDE
Label structure9 sections

Indications and uses

relieves dryness of the eye for temporary relief of discomfort and redness of the eye due to minor eye irritations for temporary relief of burning and irritation due to exposure to wind or sun for protection against further irritation

Dosage and administration

instill 1 or 2 drops in the affected eye(s) up to 4 times daily children under 6 years of age: ask a doctor

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Polyethylene glycol 400 1%

Tetrahydrozoline HCl 0.05%

Zinc Sulfate 0.25%

Purposes

OTC - PURPOSE SECTION

Lubricant

Redness reliever

Astringent

Uses

INDICATIONS & USAGE SECTION

  • relieves dryness of the eye
  • for temporary relief of discomfort and redness of the eye due to minor eye irritations
  • for temporary relief of burning and irritation due to exposure to wind or sun
  • for protection against further irritation

Warnings

WARNINGS SECTION

For external use only

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

narrow angle glaucoma

When using this product

OTC - WHEN USING SECTION

  • pupils may become enlarged temporarily
  • overuse may cause more eye redness
  • remove contact lenses before using
  • do not touch tip of container to any surface to avoid contamination
  • replace cap after using
  • do not use if this solution changes color or becomes cloudy

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you feel eye pain
  • changes in vision occur
  • redness or irritation of the eye lasts
  • condition worsens or lasts more than 72 hours

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of chlidren.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • instill 1 or 2 drops in the affected eye(s) up to 4 times daily
  • children under 6 years of age: ask a doctor

Other information

OTHER SAFETY INFORMATION

  • some users may experience a brief tingling sensation
  • store at 20°-25°C (68°-77°F)

Inactive ingredints

INACTIVE INGREDIENT SECTION

benzalkonium chloride, boric acid, edetate disodium, glycerin, hypromellose, purified water, sodium chloride, sodium citrate

Questions or comments?

OTC - QUESTIONS SECTION

Call 1-888-287-1915

Equate Multi-Symptom Eye Drops 15mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Equate Multi-Symptom Eye Drops 15mLEquate Multi-Symptom Eye Drops 15mL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2360903polyethylene glycol 400 1 % / tetrahydrozoline hydrochloride 0.05 % / zinc sulfate 0.25 % Ophthalmic SolutionPSN4
2360903polyethylene glycol 400 10 MG/ML / tetrahydrozoline hydrochloride 0.5 MG/ML / zinc sulfate 2.5 MG/ML Ophthalmic SolutionSCD4
2360903polyethylene glycol 400 1 % / tetrahydrozoline hydrochloride 0.05 % / zinc sulfate 0.25 % Ophthalmic SolutionSY4
2360903polyethylene glycol 400 10 MG/ML / tetrahydrozoline hydrochloride 0.5 MG/ML / ZnSO4 2.5 MG/ML Ophthalmic SolutionSY4

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ZINC CATION Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130194346058808GTIN-13: 0194346058808
EAN-13: 0194346058808
GTIN-12: 194346058808
UPC-A: 194346058808
GTIN storage (14 digits): 00194346058808		KC DL - Equate Multi-Symptom Relief Eye Drops.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
27945931-b6e2-158e-d615-4ef21e2af974Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
79903-159-05Equate Multi-Symptom Relief Eye Drops1 in 1 BOXSOLUTION/ DROPS14
79903-159-05Equate Multi-Symptom Relief Eye Drops15 mL in 1 BOTTLE, DROPPERSOLUTION/ DROPS154

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
79903-15979903-159-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
NameUNIIKind
ZINC SULFATE89DS0H96TBACTIB
HYPROMELLOSE, UNSPECIFIED3NXW29V3WOIACT
WATER059QF0KO0RIACT
POLYETHYLENE GLYCOL 400B697894SGQACTIB
TETRAHYDROZOLINE HYDROCHLORIDE0YZT43HS7DACTIB
BENZALKONIUM CHLORIDEF5UM2KM3W7IACT
GLYCERINPDC6A3C0OXIACT
SODIUM CHLORIDE451W47IQ8XIACT
BORIC ACIDR57ZHV85D4IACT
EDETATE DISODIUM7FLD91C86KIACT
SODIUM CITRATE1Q73Q2JULRIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Equate Multi-Symptom Relief Eye DropsPOLYETHYLENE GLYCOL 400,TETRAHYDROZOLINE HCL, ZINC SULFATEWalmart, Inc.eb8ed76b-9cd7-3636-e053-2a95a90a95832025-12-30WarningsExact identifier
ndc (package): 79903-159-05
ndc (product): 79903-159
ndc11 (package): 79903015905
spl id: 47494d02-3097-6780-e063-6294a90a5241
spl set id: eb8ed76b-9cd7-3636-e053-2a95a90a9583

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.